Actively Recruiting
Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder.
Led by Chang Gung Memorial Hospital · Updated on 2026-03-20
60
Participants Needed
1
Research Sites
177 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to evaluate the efficacy of fecal microbiota transplantation on the gastrointestinal symptoms, autistic symptoms and emotional behavior symptoms of patients with autism spectrum disorder, and investigate the relations between the brain-gut axis, cytokines and autism spectrum disorder. Fecal microbiota transplantation have the potentials to improve intestinal microbiota composition, regulate immunity, and then improve gastrointestinal symptoms, autistic symptoms, emotional behavior symptoms and sleep of children with autism spectrum disorder. Early intervention at school-age may even benefit development, improve cognition and prognosis.
CONDITIONS
Official Title
Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with autism spectrum disorder by a child psychiatrist following DSM-5 criteria
- Have gastrointestinal symptoms with a Gastrointestinal Symptoms Rating Scale score of 3 or higher
- Aged between 7 and 30 years
- Willing to participate and able to sign informed consent
You will not qualify if you...
- Unable to cooperate with fecal microbiota transplantation and examinations
- Require antibiotics within 3 months before or after study due to health conditions
- Require long-term use of proton pump inhibitors
- Have severe physical diseases such as acute gastrointestinal diseases, severe malnutrition or underweight, immunodeficiency, severe allergies or autoimmune diseases, brain injuries, or severe organic brain diseases
- Have severe mental illnesses such as schizophrenia or bipolar disorder
- Used probiotics within 1 month before the study
- Are pregnant
- Cannot understand the study content
- Unwilling to participate or refuse to sign informed consent
- Deemed unsuitable for the study by the principal investigator or co-investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Wei-Chih Chin
Taoyuan City, Taiwan, 333423
Actively Recruiting
Research Team
W
Wei-Chih Chin
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here